NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

無嗅覺症的市場規模:各類型、治療(治療、藥物)、地區 - 佔有率,預測,及機會分析(2020年∼2027年)

Anosmia Market, by Type, by Treatment (Therapies and Medications ), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 980018
出版日期 內容資訊 英文 140 Pages
商品交期: 2-3個工作天內
價格
無嗅覺症的市場規模:各類型、治療(治療、藥物)、地區 - 佔有率,預測,及機會分析(2020年∼2027年) Anosmia Market, by Type, by Treatment (Therapies and Medications ), and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年12月24日內容資訊: 英文 140 Pages
簡介

促進世界的無嗅覺症市場成長的主要原因,是嗅覺障礙的病例的增加。2019年2月The National Institute on Deafness and Other Communication Disorders發表的文章中,美國人口約3%有無嗅覺症。市場企業,以提供新產品的研究開發活動為焦點,預計在預測期間促進市場成長。

本報告提供世界的無嗅覺症市場的相關調查,市場規模和佔有率,機會和趨勢,成長及阻礙因素,各類型、治療、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的、前提條件

第2章 市場概要

  • 報告概要
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各類型
    • 市場明細:各治療
    • 市場明細:各地區
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 主要的焦點
  • 產品平台
  • 法規方案
  • 產品的銷售/核准
  • PEST分析
  • 合併和收購方案
  • 市場佔有率分析

第4章 Covid-19大流行的影響

  • COVID-19流行病學
  • 供給方面和需求面分析
  • COVID-19無嗅覺症的影響

第5章 市場分析:各類型(2016-2027)

  • 簡介
  • 特發性無嗅覺症
  • 先天性無嗅覺症

第6章 市場分析:各治療(2016-2027)

  • 簡介
  • 治療
  • 藥物

第7章 市場分析:各地區(2016-2027)

  • 簡介
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第8章 競爭情形

  • 熱圖分析
  • 企業簡介
    • Mylan NV
    • Pfizer Inc.
    • Atom Pharma
    • RANBAXY LABORATORIES LIMITED
    • Alde Medi Impex
    • GlaxoSmithkline plc
    • Sandoz (Novasrtis AG)
    • Inke SA
    • Taj Pharmaceuticals Limited
    • Sanofi
  • 分析師的見解

第9章 Section

目錄

Title:
Anosmia Market, by Type (Idiopathic Anosmia and Congenital Anosmia), by Treatment (Therapies (Nasal Endoscopy and Imaging) and Medications (Decongestants, Antihistamines, and Steroid Nasal Sprays)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Anosmia, the clinical term for the inability to smell. This disorder impair the ability to sense odors in the environment, as well as hinder the quality of life related to social interactions, eating, and feelings of well-being. It is a severe disability, affected genetically or accidentally, resulting in total/partial absence of olfactory guidance.

Market Dynamics

Rising anosmia cases is the major factor that is expected to drive growth of the global anosmia market during the forecast period. For instance, according to an article published by the National Institute on Deafness and Other Communication Disorders in February 2019, around 3% of U.S. populace have anosmia i.e.no sense of smell.

Market players are focusing on research and development activities for offering novel products for the treatment anosmia, which is expected to drive the market growth over the forecast period. For instance, in July 2020, Zydus Cadila received the U.S. Food & Drug Administration (U.S. FDA) approval for its supplemental abbreviated new drug application (SANDA) for Doxycycline Injection USP, 100 mg/vial, which seems to improve respiratory symptoms and anosmia

Key features of the study:

  • This report provides in-depth analysis of the global anosmia market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020-2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global anosmia market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Mylan N.V., Pfizer Inc., Atom Pharma, RANBAXY LABORATORIES LIMITED, Alde Medi Impex, GlaxoSmithkline plc, Sandoz (Novasrtis AG), Inke S.A., Taj Pharmaceuticals Limited, and Sanofi, amongst others.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global anosmia market report caters to various stakeholders in this industry including investors, suppliers, anosmia manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global anosmia market.

Detailed Segmentation

Global Anosmia Market, By Type

  • Idiopathic Anosmia
  • Congenital Anosmia

Global Anosmia Market, By Treatment

  • Therapies
  • Nasal Endoscopy
  • Imaging
  • Medications
  • Decongestants
  • Antihistamines
  • Steroid Nasal Sprays

Global Anosmia Market, By Region

  • North America
  • By Country
  • U.S.
  • Canada
  • By Type
  • Idiopathic Anosmia
  • Congenital Anosmia
  • By Treatment
  • Therapies
  • Nasal Endoscopy
  • Imaging
  • Medications
  • Decongestants
  • Antihistamines
  • Steroid Nasal Sprays
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Type
  • Idiopathic Anosmia
  • Congenital Anosmia
  • By Treatment
  • Therapies
  • Nasal Endoscopy
  • Imaging
  • Medications
  • Decongestants
  • Antihistamines
  • Steroid Nasal Sprays
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Type
  • Idiopathic Anosmia
  • Congenital Anosmia
  • By Treatment
  • Therapies
  • Nasal Endoscopy
  • Imaging
  • Medications
  • Decongestants
  • Antihistamines
  • Steroid Nasal Sprays
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Type
  • Idiopathic Anosmia
  • Congenital Anosmia
  • By Treatment
  • Therapies
  • Nasal Endoscopy
  • Imaging
  • Medications
  • Decongestants
  • Antihistamines
  • Steroid Nasal Sprays
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Type
  • Idiopathic Anosmia
  • Congenital Anosmia
  • By Treatment
  • Therapies
  • Nasal Endoscopy
  • Imaging
  • Medications
  • Decongestants
  • Antihistamines
  • Steroid Nasal Sprays
  • Africa
  • By Country/Region:
  • South Africa
  • Central Africa
  • North Africa
  • By Type
  • Idiopathic Anosmia
  • Congenital Anosmia
  • By Treatment
  • Therapies
  • Nasal Endoscopy
  • Imaging
  • Medications
  • Decongestants
  • Antihistamines
  • Steroid Nasal Sprays
  • Company Profiles
  • Mylan N.V.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Pfizer Inc.
  • Atom Pharma
  • RANBAXY LABORATORIES LIMITED
  • Alde Medi Impex
  • GlaxoSmithkline plc
  • Sandoz (Novasrtis AG)
  • Inke S.A.
  • Taj Pharmaceuticals Limited
  • Sanofi

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Treatment
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Key Highlights
  • Product Pipeline
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • Merger and Acquisition Scenario
  • Market Share Analysis

4. Global Anosmia Market - Impact of Coronavirus (Covid-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • COVID-19 Impact on the Anosmia

5. Global Anosmia Market, By Type, 2016 - 2027 (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Idiopathic Anosmia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
  • Congenital Anosmia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)

6. Global Anosmia Market, By Treatment, 2016 - 2027 (US$ Million)

  • Introduction
    • Market Share Analysis, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Therapies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Nasal Endoscopy
    • Imaging
  • Medications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million)
    • Decongestants
    • Antihistamines
    • Steroid Nasal Sprays

7. Global Anosmia Market, By Region, 2016 - 2027 (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2020 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2027
    • Regional Trends
  • North America
    • Market Size and Forecast, By Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Market Size and Forecast, By Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027 (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Type, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Treatment, 2016 - 2027 (US$ Mn)
    • Market Size and Forecast, By Country/Region, 2016 - 2027 (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Mylan N.V.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Pfizer Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Atom Pharma
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • RANBAXY LABORATORIES LIMITED
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Alde Medi Impex
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • GlaxoSmithkline plc
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Sandoz (Novasrtis AG)
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Inke S.A.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Taj Pharmaceuticals Limited
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
    • Sanofi
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact